p53 alterations in uterine leiomyosarcomas versus leiomyomas

Gynecologic Oncology

Volumn 54, Issue 2, 1994, Pages 205-208

  De Vos, Sven ^a,b   Wilczynski, Sharon P ^a,b   Fleischhacker, Michael ^a,b   Koeffler, Phillip ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; UTERUS MYOMA;

BASE SEQUENCE; BLOTTING, SOUTHERN; COMPARATIVE STUDY; DNA, NEOPLASM; EXONS; FEMALE; GENE AMPLIFICATION; HUMAN; LEIOMYOMA; LEIOMYOSARCOMA; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; UTERINE NEOPLASMS;

EID: 0028169369     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1006/gyno.1994.1194     Document Type: Article

References (27)

1. Rosai J. Ackerman's surgical pathology, pp. 1083-1087, Mosby, St. Louis, MO (1989).
2. Kern, S. E., Kinzler, K. W., Brunskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. Identification of p53 as a se- quence-specific DNA-binding protein, Science 252, 1708-1711 (1991).
3. Scharer, E., and Iggo, R. Mammalian p53 can function as a transcription factor, Nucleic Acids Res. 20, 1539-1545 (1992).
4. Farmer, G., Bargonetti, J., Zuhu, H., Friedman, P., Prywes, R., and Prives, C. Wild-type p53 activates transcription in vitro, Nature 358, 83-86 (1992).
5. Vogelstein, B., and Kinzler, K. W. p53 function and dysfunction, Cell 70, 523-526 (1992).
6. Stephen, C. W., and Lane, D. P. Mutant conformation of p53 precise epitope mapping using a filamentous phage epitope library, J. Mol. Biol. 225, 577-583 (1992).
7. Braithwaite, A., Sturzbecher, H. V., Addison, C., Palmer, C., Rudge, K., and Jenkins, J. Mouse p53 inhibits SV40 origin-dependent DNA replication, Nature 329, 458-460 (1987).
8. Sarnow, P., Ho, Y. S., Williams, J., and Levine, A. J. Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54kd cellular protein in transformed cells, Cell 28, 387-394 (1982).
9. Scheffner, M., Wetness, B. A., Huibreglse, M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell 63, 1129-1136 (1990).
10. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell 69, 1237-1245 (1992).
11. Soussi, T., Caron de Fromentel, C., and May, P. Structural aspects of the p53 protein in relation to gene evolution, Oncogene 5, 945-952 (1990).
12. Davis, L. G., Dibner, M. D., and Batley, J. F. Methods in molecular biology, Elsevier, New York (1986).
13. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms, Proc. Natl. Acad. Sci. USA 86, 2766-2770 (1989).
14. Lizardi, P. M., Binder, R., and Shart, S. A. Gene. Anal. Technol. 1, 33-39 (1984).
15. Murray, V. Improved double-stranded DNA sequencing using the linear polymerase chain reaction, Nucleic Acids Res. 17, 8889 (1989).
16. Feinberg, A., and Vogelstein, B. A. A technique for labeling DNA restriction fragments to high specific activity, Anal. Biochem. 14, 66-67 (1988).
17. Sreekantaiah, C., Davis, I. R., and Sandberg, A. A. Chromosomal abnormalities in leiomyosarcomas, Am. J. Pathol. 142, 293-305 (1993).
18. Hasuda, H., Miller, C., Koeffler, H. P., Battifora, H., and Cline, M. J. Rearrangement of the p53 gene in human osteogenic sarcoma, Proc. Natl. Acad. Sci. USA 84, 7716-7719 (1987).
19. Miller, C. W., Aslo, K., Tsay, C., Slamon, D., Ishizaki, K., Toguchida, J., Tamamuro, T., Lampkin, J., and Koeffler, H. P. Frequency and structure of p53 rearrangements in human osteosarcoma, Cancer Res. 50, 7950-7954 (1990).
20. Stratton, M. R., Williams, S., Fisher, C., Ball, a., Westbury, G., Gusterson, B. A., Fletcher C. D. M., Knight, J. C., Fung, Y-K., Reeves, B. R., and Cooper, C. S. Structural alterations of the RB- 1 gene in human soft tissue tumors, Br. J. Cancer 60, 202-205 (1989).
21. Kraiss, S., Spiess, S., Reihsaus, E., and Montenarh, M. Correlation of metabolic stability and altered quartemary structure of oncoprotein p53 with cell transformation, Exp. Cell Res. 192, 157-164 (1991).
22. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas, Nature 358, 80-83 (1992).
23. Montague, A., Swartz, D. P., and Woodruff, S. D. Sarcoma arising in leiomyoma of uterus, Am. J. Obstet. Gynecol. 92, 421 (1965).
24. Silverberg, S. G. Leiomyosarcoma of the uterus. A climcopathologic study, Obstet. Gynecol. 38, 613-628 (1971).
25. Spiro, R. H., and Koss, L. G. Myosarcoma of the uterus, Cancer 571 (1965).
26. Drogemueller, W., Herbst, A. L., Mishell, D. R., and Stenchever, M. A. (Eds.). Comprehensive gynecology, Mosby, St. Louis, MO (1987).
27. Evans, H. L., Chawla, S. P., Simpson, C., and Fin, K. P. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases with emphasis on diagnostic criteria and prognostic factors, Cancer 62, 2239-2247 (1988).